Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Heuberger JAAC"'
Publikováno v:
British journal of clinical pharmacology, vol. 88, no. 2, pp. 566-578
The creation of WADA contributed to harmonization of anti-doping and changed doping behavior and prevalence in the past 22 years. However, the system has developed important deficiencies and limitations that are causing harm to sports, athletes and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::eb8516e3b3b71c55ba6175ea183005e3
https://serval.unil.ch/notice/serval:BIB_D8B2E5B871B9
https://serval.unil.ch/notice/serval:BIB_D8B2E5B871B9
Autor:
Gorbenko AA; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Heuberger JAAC; Centre for Human Drug Research, Leiden, The Netherlands., Klumpers LE; Verdient Science, Denver, Colorado, USA.; Tomori Pharmacology, Denver, Colorado, USA.; Larner College of Medicine, University of Vermont, Burlington, Vermont, USA., de Kam ML; Centre for Human Drug Research, Leiden, The Netherlands., Strugala PK; Centre for Human Drug Research, Leiden, The Netherlands., de Visser SJ; Centre for Future Affordable and Sustainable Therapy Development (FAST), The Hague, The Netherlands., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Nov; Vol. 116 (5), pp. 1289-1303. Date of Electronic Publication: 2024 Jul 25.
Autor:
Skov M; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Ruijs TQ; Centre for Human Drug Research, 2333 CL Leiden, Netherlands.; Leiden University Medical Centre, 2333 ZA Leiden, Netherlands., Grønnebæk TS; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Skals M; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Riisager A; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Winther JB; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Dybdahl KLT; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Findsen A; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Morgen JJ; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Huus N; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Broch-Lips M; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Nielsen OB; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark.; Department of Biomedicine, Aarhus University, Ole Worms Alle 4, 8000 Aarhus C, Denmark., de Cuba CMKE; Centre for Human Drug Research, 2333 CL Leiden, Netherlands.; Leiden University Medical Centre, 2333 ZA Leiden, Netherlands., Heuberger JAAC; Centre for Human Drug Research, 2333 CL Leiden, Netherlands., de Kam ML; Centre for Human Drug Research, 2333 CL Leiden, Netherlands., Tannemaat M; Leiden University Medical Centre, 2333 ZA Leiden, Netherlands., Verschuuren JJGM; Leiden University Medical Centre, 2333 ZA Leiden, Netherlands., Knutsen LJS; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Kelly NM; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Jensen KG; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Arnold WD; NextGen Precision Health, University of Missouri, 1030 Hitt St, Columbia, MO 65212, USA., Burghes AH; Department of Biological Chemistry and Pharmacology, Ohio State University Wexner Medical Center, 1060 Carmack Road, Columbus, OH 43210, USA.; Department of Neurology, Neuromuscular Division, Ohio State University Wexner Medical Center, 395 W. 12(th) Ave, Columbus, OH 43210, USA., Olesen C; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark.; Department of Biomedicine, Aarhus University, Ole Worms Alle 4, 8000 Aarhus C, Denmark., Bold J; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Petersen TK; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Quiroz JA; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Hutchison J; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Chin ER; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark., Groeneveld GJ; Centre for Human Drug Research, 2333 CL Leiden, Netherlands.; Leiden University Medical Centre, 2333 ZA Leiden, Netherlands., Pedersen TH; NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark.; Department of Biomedicine, Aarhus University, Ole Worms Alle 4, 8000 Aarhus C, Denmark.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Mar 20; Vol. 16 (739), pp. eadk9109. Date of Electronic Publication: 2024 Mar 20.
Autor:
Dijkstra FM; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Center, Leiden, ZA, the Netherlands., Zuiker RGJA; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Center, Leiden, ZA, the Netherlands., Heuberger JAAC; Centre for Human Drug Research, Leiden, the Netherlands., Kanhai KMS; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Center, Leiden, ZA, the Netherlands., De Kam M; Centre for Human Drug Research, Leiden, the Netherlands., Duvauchelle T; Bioprojet Pharma, Paris, France., Lecomte JM; Bioprojet Pharma, Paris, France., Labeeuw O; Bioprojet Biotech, Saint Gregoire, France., Landais L; Bioprojet Biotech, Saint Gregoire, France., Ligneau X; Bioprojet Biotech, Saint Gregoire, France., Robert P; Bioprojet Biotech, Saint Gregoire, France., Capet M; Bioprojet Biotech, Saint Gregoire, France., Schwartz JC; Bioprojet Pharma, Paris, France., van Gerven JMA; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Center, Leiden, ZA, the Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Jan; Vol. 90 (1), pp. 321-335. Date of Electronic Publication: 2023 Oct 11.
Autor:
Vissers MFJM; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., Troyer MD; Denali Therapeutics Inc., South San Francisco, California, USA., Thijssen E; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., Pereira DR; Denali Therapeutics Inc., South San Francisco, California, USA., Heuberger JAAC; Centre for Human Drug Research, Leiden, The Netherlands., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., Huntwork-Rodriguez S; Denali Therapeutics Inc., South San Francisco, California, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2023 Aug; Vol. 16 (8), pp. 1408-1420. Date of Electronic Publication: 2023 May 15.
Autor:
Jennings D; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Huntwork-Rodriguez S; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Vissers MFJM; Centre for Human Drug Research, Leiden, the Netherlands.; Department of Clinical Neuropharmacology, Leiden University Medical Center, Leiden, the Netherlands., Daryani VM; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Diaz D; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Goo MS; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Chen JJ; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Maciuca R; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Fraser K; Biogen Inc, Cambridge, Massachusetts, USA., Mabrouk OS; Biogen Inc, Cambridge, Massachusetts, USA., van de Wetering de Rooij J; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA.; PRA Health Sciences, Groningen, the Netherlands., Heuberger JAAC; Centre for Human Drug Research, Leiden, the Netherlands., Groeneveld GJ; Centre for Human Drug Research, Leiden, the Netherlands.; Department of Clinical Neuropharmacology, Leiden University Medical Center, Leiden, the Netherlands., Borin MT; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Cruz-Herranz A; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Graham D; Biogen Inc, Cambridge, Massachusetts, USA., Scearce-Levie K; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., De Vicente J; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Henry AG; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Chin P; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Ho C; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA., Troyer MD; SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2023 Mar; Vol. 38 (3), pp. 386-398. Date of Electronic Publication: 2023 Feb 18.
Autor:
Ruijs TQ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Koopmans IW; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., de Kam ML; Centre for Human Drug Research, Leiden, The Netherlands., Tannemaat MR; Leiden University Medical Centre, Leiden, The Netherlands., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Heuberger JAAC; Centre for Human Drug Research, Leiden, The Netherlands.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2022 Dec; Vol. 15 (12), pp. 2971-2981. Date of Electronic Publication: 2022 Oct 25.
Autor:
Ruijs TQ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Koopmans IW; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., de Kam ML; Centre for Human Drug Research, Leiden, The Netherlands., van Esdonk MJ; Centre for Human Drug Research, Leiden, The Netherlands., Koltzenburg M; National Hospital for Neurology and Neurosurgery, London, UK., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Heuberger JAAC; Centre for Human Drug Research, Leiden, The Netherlands.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Nov; Vol. 112 (5), pp. 1008-1019. Date of Electronic Publication: 2022 Jul 19.
Autor:
Vissers MFJM; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., Heuberger JAAC; Centre for Human Drug Research, Leiden, The Netherlands., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., Oude Nijhuis J; Department of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., De Deyn PP; Department of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Laboratory of Neurochemistry and Behavior, Department of Biomedical Sciences and Institute Born-Bunge, University of Antwerp, Antwerp, Belgium., Hadi S; PRA Health Sciences, Groningen, The Netherlands., Harris J; Denali Therapeutics Inc., South San Francisco, California, USA., Tsai RM; Denali Therapeutics Inc., South San Francisco, California, USA., Cruz-Herranz A; Denali Therapeutics Inc., South San Francisco, California, USA., Huang F; Denali Therapeutics Inc., South San Francisco, California, USA., Tong V; Denali Therapeutics Inc., South San Francisco, California, USA., Erickson R; Denali Therapeutics Inc., South San Francisco, California, USA., Zhu Y; Denali Therapeutics Inc., South San Francisco, California, USA., Scearce-Levie K; Denali Therapeutics Inc., South San Francisco, California, USA., Hsiao-Nakamoto J; Denali Therapeutics Inc., South San Francisco, California, USA., Tang X; Denali Therapeutics Inc., South San Francisco, California, USA., Chang M; Denali Therapeutics Inc., South San Francisco, California, USA., Fox BM; Denali Therapeutics Inc., South San Francisco, California, USA., Estrada AA; Denali Therapeutics Inc., South San Francisco, California, USA., Pomponio RJ; Sanofi Genzyme, Cambridge, Massachusetts, USA., Alonso-Alonso M; Sanofi Genzyme, Cambridge, Massachusetts, USA., Zilberstein M; Sanofi Genzyme, Cambridge, Massachusetts, USA., Atassi N; Sanofi Genzyme, Cambridge, Massachusetts, USA., Troyer MD; Denali Therapeutics Inc., South San Francisco, California, USA., Ho C; Denali Therapeutics Inc., South San Francisco, California, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2022 Aug; Vol. 15 (8), pp. 2010-2023. Date of Electronic Publication: 2022 Jun 01.
Autor:
Sleutjes BTHM; Department of Neurology, Brain Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands., Stikvoort García DJL; Department of Neurology, Brain Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands., Kovalchuk MO; Department of Neurology, Brain Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands., Heuberger JAAC; Center for Human Drug Research, Leiden, The Netherlands., Groeneveld GJ; Center for Human Drug Research, Leiden, The Netherlands., Franssen H; Department of Neurology, Brain Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands., van den Berg LH; Department of Neurology, Brain Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2022 Aug; Vol. 10 (4), pp. e00983.